The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Multifocal prostate cancer: biologic, prognostic, and therapeutic implications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Schlaberg, R., Choe, D. J., Brown, K. R., Thaker, H. M., & Singh, I. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906922106 · Cited by 275
RetractedJemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846 · cited 1×
“Several recent studies have pointed to observed fusions of the androgen-regulated gene TMPRSS2, and the ETS transcription factor family members, particularly ERG, as highly common and significant genomic alterations seen in prostate cancer [74,78-81].”
BackgroundNatural History of Progression After PSA Elevation Following Radical Prostatectomy
Pound, C. R. (1999) · JAMA · doi:10.1001/jama.281.17.1591 · Cited by 3,071
Beahrs, O. H., & Henson, D. E. (1992) · Medical Entomology and Zoology · Cited by 2,460
Gleason, D. F., Mellinger, G. T., & The Veterans Administration Cooperative Urological Research Group Members of this group areS0022534717598894-57c401330b4195dbd1713587ed540477 Lino J. Arduino Veterans Administration Center (VAC), D. M. (1974) · Journal of Urology · doi:10.1016/s0022-5347(17)59889-4 · Cited by 2,214
Inflammation in prostate carcinogenesis
De Marzo, A. M., Platz, E. A., Sutcliffe, S., Xu, J., Grönberg, H., Drake, C. G., Nakai, Y., Isaacs, W. B., & Nelson, W. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2090 · Cited by 1,621
McNeal, J. E., Redwine, E. A., Freiha, F. S., & Stamey, T. A. (1988) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198812000-00001 · Cited by 1,182
Classification of prostatic carcinomas.
Gleason, D. F. (1966) · PubMed · Cited by 1,110
Histologic grading of prostate cancer: A perspective
Gleason, D. F. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90108-f · Cited by 1,034
Hövels, A. M., Heesakkers, R. A. M., Adang, E. M., Jager, G. J., Strum, S., Hoogeveen, Y. L., Severens, J. L., & Barentsz, J. O. (2008) · Clinical Radiology · doi:10.1016/j.crad.2007.05.022 · Cited by 954
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Zincke, H., Oesterling, J. E., Blute, M. L., Bergstralh, E. J., Myers, R. P., & Barrett, D. M. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32399-6 · Cited by 672
Recurrent gene fusions in prostate cancer
Kumar-Sinha, C., Tomlins, S. A., & Chinnaiyan, A. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2402 · Cited by 664
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Liu, W., Laitinen, S., Khan, S., Vihinen, M., Kowalski, J., Yu, G., Chen, L., Ewing, C. M., Eisenberger, M. A., Carducci, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1944 · Cited by 654
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J.-M., Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210237 · Cited by 645
PATTERNS OF PROGRESSION IN PROSTATE CANCER
Mcneal, J., Kindrachuk, R., Freiha, F., Bostwick, D., Redwine, E., & Stamey, T. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90715-4 · Cited by 582
TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
Perner, S., Demichelis, F., Beroukhim, R., Schmidt, F. H., Mosquera, J.-M., Setlur, S., Tchinda, J., Tomlins, S. A., Hofer, M. D., Pienta, K. G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1482 · Cited by 502
Regional Morphology and Pathology of The Prostate
McNeal, J. E. (1968) · American Journal of Clinical Pathology · doi:10.1093/ajcp/49.3.347 · Cited by 477
TMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate Cancer
Tomlins, S. A., Mehra, R., Rhodes, D. R., Smith, L. R., Roulston, D., Helgeson, B. E., Cao, X., Wei, J. T., Rubin, M. A., Shah, R. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0168 · Cited by 469
Jenkins, R. B., Qian, J., Lieber, M. M., & Bostwick, D. G. (1997) · PubMed · Cited by 443
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
Gurel, B., Iwata, T., M Koh, C., Jenkins, R. B., Lan, F., Van Dang, C., Hicks, J. L., Morgan, J., Cornish, T. C., Sutcliffe, S., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.111 · Cited by 441
TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion
Perner, S., Mosquera, J.-M., Demichelis, F., Hofer, M. D., Paris, P. L., Simko, J., Collins, C., Bismar, T. A., Chinnaiyan, A. M., De Marzo, A. M., et al. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213424.38503.aa · Cited by 426
Wang, J., Cai, Y., Ren, C., & Ittmann, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1966 · Cited by 404
High-grade prostatic intraepithelial neoplasia
Bostwick, D. G., & Qian, J. (2004) · Modern Pathology · doi:10.1038/modpathol.3800053 · Cited by 345
McNeal, J. E. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90106-d · Cited by 300
Management of Cancer of the Prostate
Wood, A. J. J., & Catalona, W. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311507 · Cited by 294
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia.
Emmert‐Buck, M. R., Vocke, C. D., Pozzatti, R., Duray, P. H., Jennings, S. B., Florence, C., Zhuang, Z., Bostwick, D. G., Liotta, L. A., & Linehan, W. M. (1995) · PubMed · Cited by 293
A molecular correlate to the Gleason grading system for prostate adenocarcinoma
True, L., Coleman, I., Hawley, S., Huang, C.-Y., Gifford, D., Coleman, R., Beer, T. M., Gelmann, E., Datta, M., Mostaghel, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603678103 · Cited by 291
Emi, M., Fujiwara, Y., Nakajima, T., Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M., & Nakamura, Y. (1992) · PubMed · Cited by 268
A Quantitative Promoter Methylation Profile of Prostate Cancer
Jerónimo, C., Henrique, R., Hoque, M. O., Mambo, E., Ribeiro, F. R., Varzim, G., Oliveira, J., Teixeira, M. R., Lopes, C., & Sidransky, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0894 · Cited by 260
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Gopalan, A., Leversha, M. A., Satagopan, J. M., Zhou, Q., Al-Ahmadie, H. A., Fine, S. W., Eastham, J. A., Scardino, P. T., Scher, H. I., Tickoo, S. K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2467 · Cited by 246
TMPRSS2 : ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
Saramäki, O. R., Harjula, A. E., Martikainen, P. M., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2051 · Cited by 243
Magi-Galluzzi, C. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31819697f4 · Cited by 230
Mehra, R., Han, B., Tomlins, S. A., Wang, L., Menon, A., Wasco, M. J., Shen, R., Montie, J. E., Chinnaiyan, A. M., & Shah, R. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2043 · Cited by 214
Prostate Cancer Susceptibility Locus on Chromosome 1q: a Confirmatory Study
Cooney, K. A., Huang, L., Sandler, H. M., Lange, E., Lange, K., Miesfeldt, S., McCarthy, J. D., Montie, J. E., & Oesterling, J. E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.13.955 · Cited by 202
Bostwick, D. G., Shan, A., Qian, J., Darson, M. F., Maihle, N. J., Jenkins, R. B., & Liang Cheng, C. (1998) · Cancer · Cited by 199
Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer
Soller, M. J., Isaksson, M., Elfving, P., Soller, W., Lundgren, R., & Panagopoulos, I. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20329 · Cited by 195
DJAVAN, B., ROEHRBORN, C. G., SHARIAT, S., GHAWIDEL, K., & MARBERGER, M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)62084-6 · Cited by 186
HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS
RUIJTER, E. T., VAN DE KAA, C. A., SCHALKEN, J. A., DEBRUYNE, F. M., & RUITER, D. J. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199611)180:3<295::aid-path663>3.0.co;2-w · Cited by 184
TMPRSS2-ERG Fusion Heterogeneity in Multifocal Prostate Cancer: Clinical and Biologic Implications
Barry, M., Perner, S., Demichelis, F., & Rubin, M. A. (2007) · Urology · doi:10.1016/j.urology.2007.08.032 · Cited by 156
Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer
Fischer, N., Hellwinkel, O., Schulz, C., Chun, F. K. ‐., Huland, H., Aepfelbacher, M., & Schlomm, T. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2008.04.016 · Cited by 140
Bastacky, S., Wojno, K. J., Walsh, P. C., Carmichael, M. J., & Epstein, J. I. (1995) · The Journal of Urology · doi:10.1097/00005392-199503001-00023 · Cited by 119
Original Articles: Prostate Cancer: Pathological Features of Hereditary Prostate Cancer
Bastacky, S., Wojno, K. J., Walsh, P. C., Carmichael, M. J., & Epstein, J. I. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67619-5 · Cited by 117
Qian, J., Jenkins, R. B., & Bostwick, D. G. (1997) · PubMed · Cited by 113
Hattab, E. M., Koch, M. O., Eble, J. N., Lin, H., & Liang Cheng, C. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00998-5 · Cited by 102
Cancer of the Prostate: Epidemiology and Aetiology
Zaridze, D. G., & Boyle, P. (1987) · British Journal of Urology · doi:10.1111/j.1464-410x.1987.tb04862.x · Cited by 101
Cheville, J. C., Karnes, R. J., Therneau, T. M., Kosari, F., Munz, J.-M., Tillmans, L. S., Basal, E., Rangel, L. J., Bergstralh, E. J., Kovtun, I. V., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6752 · Cited by 84
MT1G Hypermethylation Is Associated with Higher Tumor Stage in Prostate Cancer
Henrique, R., Jerónimo, C., Hoque, M. O., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0659 · Cited by 70
Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy
Liang Cheng, C., Davidson, D. D., Lin, H., & Koch, M. O. (2007) · Cancer · doi:10.1002/cncr.23004 · Cited by 66
Patel, A. A., Chen, M., Renshaw, A. A., & D'Amico, A. V. (2007) · JAMA · doi:10.1001/jama.298.13.1533 · Cited by 65
Prostate cancer of transition zone origin lacks TMPRSS2–ERG gene fusion
Guo, C. C., Zuo, G., Cao, D., Troncoso, P., & Czerniak, B. A. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.57 · Cited by 64
Dedifferentiation in the metastatic progression of prostate carcinoma
Cheng, L., Slezak, J. M., Bergstralh, E. J., Cheville, J. C., SWEAT, S. D., Zincke, H., & Bostwick, D. G. (1999) · Cancer · Cited by 61
Self-citationFrequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma.
Fujiwara, Y., Monden, M., Mori, T., Nakamura, Y., & Emi, M. (1993) · PubMed · Cited by 60
TRANSITION ZONE CANCERS UNDERMINE THE PREDICTIVE ACCURACY OF PARTIN TABLE STAGE PREDICTIONS
Steuber, T. P., Karakiewicz, P. I., Augustin, H., Erbersdobler, A., LANGE, I., Haese, A., Chun, F. K. ‐., Walz, J. C., Graefen, M., & Huland, H. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000152591.33259.f9 · Cited by 48
Sakai, I., Harada, K., Kurahashi, T., Yamanaka, K., Hara, I., & Miyake, H. (2006) · International Journal of Urology · doi:10.1111/j.1442-2042.2006.01307.x · Cited by 46
Fleming, I. D., Phillips, J. L., Menck, H. R., Murphy, G. P., & Winchester, D. P. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971215)80:12<2305::aid-cncr12>3.0.co;2-y · Cited by 36
Bostwick, D. G., & Meiers, I. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-01970-5.50011-7 · Cited by 29
(1992) · PubMed
Cited by
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Ding, Z., Wu, C.-J., Chu, G. C., Xiao, Y., Ho, D., Zhang, J., Perry, S. R., Labrot, E. S., Wu, X., Lis, R., et al. (2011) · Nature · doi:10.1038/nature09677 · Cited by 515
Genomic and phenotypic heterogeneity in prostate cancer
Haffner, M. C., Zwart, W., Roudier, M. P., True, L. D., Nelson, W. G., Epstein, J. I., De Marzo, A. M., Nelson, P. S., & Yegnasubramanian, S. (2021) · Nature Reviews Urology · doi:10.1038/s41585-020-00400-w · Cited by 502
the ICGC Prostate Group, Cooper, C. S., Eeles, R., Wedge, D. C., Van Loo, P., Gundem, G., Alexandrov, L. B., Kremeyer, B., Butler, A., Lynch, A. G., et al. (2015) · Nature Genetics · doi:10.1038/ng.3221 · Cited by 434
Ren, S., Peng, Z., Mao, J.-H., Yu, Y., Yin, C., Gao, X., Cui, Z., Zhang, J., Yi, K., Xu, W., et al. (2012) · Cell Research · doi:10.1038/cr.2012.30 · Cited by 362
Mierke, C. T. (2019) · Reports on Progress in Physics · doi:10.1088/1361-6633/ab1628 · Cited by 262
Metadata
- Authors
- Andreoiu, M., & Cheng, L.
- Venue
- Human Pathology
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 41
- Issue
- 6
- Pages
- 781-793
- ISSN
- 0046-8177 (ISSN-L)
- OpenAlex
- W1996570931
- Cited by
- 301
- References
- 59
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.